Wong-Chew Rosa María, Noyola Daniel Ernesto, Villa Antonio Rafael
División de Investigación, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, México.
Departamento de Microbiología, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, Ciudad de México, México.
An Pediatr (Barc). 2022 Aug;97(2):119-128. doi: 10.1016/j.anpedi.2021.07.014. Epub 2021 Sep 27.
In the paediatric population, coronavirus disease (COVID-19) is usually asymptomatic or mild, but there are also severe and fatal cases.
We analysed data on COVID-19 cases from the national and state-level databases of the Federal Ministry of Health of Mexico and the Department of Health of Mexico City to determine the clinical characteristics and risk factors for mortality in children. We used Cox proportional hazards regression analysis to calculate the risk of death.
The national and Mexico City databases had recorded a total of 18,465 (2.8%) and 5,733 (4.2%) confirmed cases of COVID-19, respectively, in individuals aged less than 18 years as of September 2020. The median age at diagnosis was 12 years (range: 0-17). The differences between cases in the national vs Mexico City databases were: 12.5% vs 8.2% of patients were hospitalised; 6% vs 3.5% had pneumonia; 2.4% vs 1.9% were admitted to the intensive care unit (ICU), and 1.3% vs 0.7% died. The independent risk factors significantly associated with a higher probability of death were pneumonia, hypertension, obesity, immunosuppression and intubation.
In Mexico, 2.8% of all confirmed cases of COVID-19 occurred in individuals under 18 years, with a median age of 12 years and a mortality of 1.3%. The identified predictors of mortality were pneumonia, admission to the ICU, obesity, hypertension, immunosuppression, diabetes, chronic lung disease and renal disease.
在儿科人群中,冠状病毒病(COVID-19)通常无症状或症状轻微,但也有严重和致命病例。
我们分析了来自墨西哥联邦卫生部和墨西哥城卫生部国家级及州级数据库中COVID-19病例的数据,以确定儿童的临床特征和死亡风险因素。我们使用Cox比例风险回归分析来计算死亡风险。
截至2020年9月,国家级和墨西哥城数据库分别记录了18465例(2.8%)和5733例(4.2%)18岁以下确诊的COVID-19病例。诊断时的中位年龄为12岁(范围:0至17岁)。国家级数据库与墨西哥城数据库病例之间的差异为:住院患者比例分别为12.5%和8.2%;肺炎患者比例分别为6%和3.5%;入住重症监护病房(ICU)的患者比例分别为2.4%和1.9%;死亡患者比例分别为1.3%和0.7%。与死亡概率较高显著相关的独立风险因素为肺炎、高血压、肥胖、免疫抑制和插管。
在墨西哥,所有确诊的COVID-19病例中有2.8%发生在18岁以下个体中,中位年龄为12岁,死亡率为1.3%。确定的死亡预测因素为肺炎、入住ICU、肥胖、高血压、免疫抑制、糖尿病、慢性肺病和肾病。